Provided by Tiger Trade Technology Pte. Ltd.

NEXGEL, INC.

0.3692
+0.01042.90%
Volume:126.96K
Turnover:45.14K
Market Cap:3.60M
PE:-0.49
High:0.3699
Open:0.3487
Low:0.3317
Close:0.3588
52wk High:2.89
52wk Low:0.3001
Shares:9.75M
Float Shares:7.82M
Volume Ratio:1.25
T/O Rate:1.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7502
EPS(LYR):-0.3820
ROE:-115.07%
ROA:-18.67%
PB:0.73
PE(LYR):-0.97

Loading ...

Nexgel appoints Sequence LifeScience executives Brian Kieser, Kevin Harris to board

Reuters
·
May 06

Nexgel names Ian Blackman chief financial officer

Reuters
·
May 01

Celularity FY25 operating loss widens to $61.31 million; revenue drops 51% to $26.55 million

Reuters
·
May 01

Nexgel appoints Ian Blackman as CFO

Reuters
·
Apr 27

NexGel gets Nasdaq notice for failing $1 minimum bid price rule

Reuters
·
Apr 25

BRIEF-Nexgel Inc Co And Celularity Enter Amendment No. 1 To License Agreement On April 17, 2026

Reuters
·
Apr 22

Nexgel Inc - Co and Celularity Enter Amendment No. 1 to License Agreement on April 17, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 22

Nexgel Inc - Co to Pay Celularity $13.3 Mln Including $8.3 Mln Cash and $5 Mln Convertible Note - SEC Filing

THOMSON REUTERS
·
Apr 22

Nexgel partners with Sequence LifeScience in $5.5 million financing for Celularity deal

Reuters
·
Apr 21

Celularity closes biomaterials asset sale and license deal with NexGel for $13.3 million

Reuters
·
Apr 21

NexGel Q4 EPS $(0.12) Misses $(0.09) Estimate, Sales $2.796M Miss $3.240M Estimate

Benzinga Earnings
·
Apr 01

Nexgel Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 28

Nexgel updates its financial calendar; management hosts a conference call at 4:30 P.M. ET

Reuters
·
Mar 25

Nexgel Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Mar 21

NexGel price target lowered to $2 from $6 at Maxim

TIPRANKS
·
Mar 12

Nexgel Inc - Consideration Includes $15 Mln Upfront Cash and up to $20 Mln in Milestone Payments

THOMSON REUTERS
·
Mar 12

Nexgel Inc - Deal Expected to Triple Annual Revenue to $35 Mln and Make Company Profitable Upon Closing

THOMSON REUTERS
·
Mar 12

Celularity reiterates strategic commercialization partnership with NEXGEL

TIPRANKS
·
Mar 12

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

GlobeNewswire
·
Mar 12

NexGel sign agreement to license, acquire portfolio of products from Celularity

TIPRANKS
·
Mar 10